Artemisinin and curcumin inhibit Drosophila brain tumor, prolong life span, and restore locomotor activity

IUBMB Life

Volumn 66, Issue 7, 2014, Pages 496-506

  Das, Sourajit Soumyaranjan ^a   Nanda, Gargi Gouranga ^a   Alone, Debasmita Pankaj ^a  

^a NATIONAL INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

antitumor; locomotion; longevity; natural products; reactive oxygen species

Indexed keywords

ARTEMISININ; CURCUMIN; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; ARTEMISININ DERIVATIVE;

ARTICLE; BRAIN FUNCTION; BRAIN TUMOR; CANCER INHIBITION; DROSOPHILA MELANOGASTER; DRUG EFFICACY; DRUG MECHANISM; GENE DELETION; LIFESPAN; LOCOMOTION; LONGEVITY; TUMOR SUPPRESSOR GENE; ANIMAL; BRAIN NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; METABOLISM; MOTOR ACTIVITY;

DROSOPHILA MELANOGASTER; MUS;

ANIMALS; ANTINEOPLASTIC AGENTS; ARTEMISININS; BRAIN NEOPLASMS; CURCUMIN; DROSOPHILA MELANOGASTER; DRUG SCREENING ASSAYS, ANTITUMOR; LONGEVITY; MOTOR ACTIVITY; REACTIVE OXYGEN SPECIES;

EID: 84906348580     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1284     Document Type: Article

References (55)

1. Ferlay, J., Shin H. R., Bray, F., Forman, D., Mathers, C., et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917.
2. Crespo-Ortiz, M. P., and, Wei, M. Q., (2012) Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J. Biomed. Biotechnol. 2012, 247597.
3. Jutooru, I., Chadalapaka, G., Lei, P., and, Safe, S., (2010) Inhibition of NFκB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J. Biol. Chem. 285, 25332-25344.
4. Lu, J. J., Cai, Y. J., and, Ding, J., (2011) Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cells. Mol. Cell. Biochem. 354, 247-252.
5. LoTempio, M. M., Veena, M. S., Steele, H. L., Ramamurthy, B., Ramalingam, T. S., et al. (2005) Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin. Cancer Res. 11, 6994-7002.
6. Pandey, U. B., and, Nichols, C. D., (2011) Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol. Rev. 63, 411-436.
7. Huo, G., Lu, J., Qu, Z., Lin, Z., Zhang, D., et al. (2014) The applications and advantages of Drosophila melanogaster in cancer research. Hereditas 36, 30-40.
8. Mechler, B. M., Strand, D., Kalmes, A., Merz, R., Schmidt, M., et al. (1991) Drosophila as a model system for molecular analysis of tumorigenesis. Environ. Health Perspect. 93, 63-71.
9. Potter, C. J., Turenchalk, G. S., and, Xu, T., (2000) Drosophila in cancer research. An expanding role. Trends Genet. 16, 33-39.
10. Green, M. M., and, Shepherd, S. H., (1979) Genetic instability in Drosophila melanogaster: the induction of specific chromosome 2 deletions by MR elements. Genetics 92, 823-832.
11. Woodhouse, E. C., Fisher, A., Bandle, R. W., Bryant-Greenwood, B., Charboneau, L., et al. (2003) Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype. Proc. Natl. Acad. Sci. USA 100, 11463-11468.
12. Nedelcheva, M., Topouzova, T., and, Genova, G., (2001) Transcription of Dfos is stimulated by brain tumours of l(2)gl-deficient larvae of Drosophila melanogaster. Int. J. Biochem. Cell Biol. 33, 45-51.
13. Schimanski, C. C., Schmitz, G., Kashyap, A., Bosserhoff, A. K., Bataille, F., et al. (2005) Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 24, 3100-3109.
14. Zimmermann, T., Kashyap, A., Hartmann, U., Otto, G., Galle, P. R., et al. (2008) Cloning and characterization of the promoter of Hugl-2, the human homologue of Drosophila lethal giant larvae (lgl) polarity gene. Biochem. Biophys. Res. Commun. 366, 1067-1073.
15. Klezovitch, O., Fernandez, T. E., Tapscott, S. J., and, Vasioukhin, V., (2004) Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice. Genes Dev. 18, 559-571.
16. Merz, R., Schmidt, M., Torok, I., Protin, U., Schuler, G., et al. (1990) Molecular action of the l(2)gl tumor suppressor gene of Drosophila melanogaster. Environ. Health Perspect. 88, 163-167.
17. Woodhouse, E., Hersperger, E., and, Shearn, A., (1998) Growth, metastasis, and invasiveness of Drosophila tumors caused by mutations in specific tumor suppressor genes. Dev. Genes Evol. 207, 542-550.
18. Gateff, E., (1978) Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 200, 1448-1459.
19. Hadorn, E., (1937) An accelerating effect of normal "ring- glands" on puparium-formation in lethal larvae of Drosophila Melanogaster. Proc. Natl. Acad. Sci. USA 23, 478-484.
20. Wilken, R., Veena, M. S., Wang, M. B., and, Srivatsan, E. S., (2011) Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 10, 12.
21. Reddy, L., Odhav, B., and, Bhoola, K. D., (2003) Natural products for cancer prevention: a global perspective. Pharmacol. Ther. 99, 1-13.
22. Zhang, B., Freeman, M. R., and, Waddell, S., (2010) Drosophila Neurobiology: A Laboratory Manual. p. 7, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
23. Alone, D. P., Tiwari, A. K., Mandal, L., Li M., Mechler, B. M., et al. (2005) Rab11 is required during Drosophila eye development. Int. J. Dev. Biol. 49, 873-879.
24. Owusu-Ansah, E., and, Banerjee, U., (2009) Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 461, 537-541.
25. Lee, K. S., Lee, B. S., Semnani, S., Avanesian, A., Um, C. Y., et al. (2010) Curcumin extends life span, improves health span, and modulates the expression of age-associated aging genes in Drosophila melanogaster. Rejuvenation Res. 13, 561-570.
26. Caldwell, J. C., Miller, M. M., Wing, S., Soll, D. R., and, Eberl, D. F., (2003) Dynamic analysis of larval locomotion in Drosophila chordotonal organ mutants. Proc. Natl. Acad. Sci. USA 100, 16053-16058.
27. Yang, J. S., Nam, H. J., Seo, M., Han, S. K., Choi, Y., et al. (2011) OASIS: online application for the survival analysis of lifespan assays performed in aging research. PLoS One 6, e23525.
28. Nowakowski, R. S., Lewin, S. B., and, Miller, M. W., (1989) Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population. J. Neurocytol. 18, 311-318.
29. Truman, J. W., and, Bate, M., (1988) Spatial and temporal patterns of neurogenesis in the central nervous system of Drosophila melanogaster. Dev. Biol. 125, 145-157.
30. Gateff, E., (1994) Tumor suppressor and overgrowth suppressor genes of Drosophila melanogaster: developmental aspects. Int. J. Dev. Biol. 38, 565-590.
31. Chia, W., Somers, W. G., and, Wang, H., (2008) Drosophila neuroblast asymmetric divisions: cell cycle regulators, asymmetric protein localization, and tumorigenesis. J. Cell Biol. 180, 267-272.
32. Colonques, J., Ceron, J., Reichert, H., and, Tejedor, F. J., (2011) A transient expression of Prospero promotes cell cycle exit of Drosophila postembryonic neurons through the regulation of Dacapo. PLoS One 6, e19342.
33. Szatrowski, T. P., and, Nathan, C. F., (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51, 794-798.
34. Trachootham, D., Alexandre, J., and, Huang, P., (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8, 579-591.
35. Gateff, E., and, Schneiderman, H. A., (1969) Neoplasms in mutant and cultured wild-type tissues of Drosophila. Natl. Cancer Inst. Monogr. 31, 365-397.
36. Caesar, I., Jonson, M., Nilsson, K. P., Thor, S., and, Hammarstrom, P., (2012) Curcumin promotes A-β fibrillation and reduces neurotoxicity in transgenic Drosophila. PLoS One 7, e31424.
37. Read, R. D., (2011) Drosophila melanogaster as a model system for human brain cancers. Glia 59, 1364-1376.
38. Chaturvedi, D., Goswami, A., Saikia, P. P., Barua, N. C., and, Rao, P. G., (2010) Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. Chem. Soc. Rev. 39, 435-454.
39. Cragg, G. M., and, Newman, D. J., (2005) Plants as a source of anti-cancer agents. J. Ethnopharmacol. 100, 72-79.
40. Brewer, T. G., Genovese, R. F., Newman, D. B., and, Li, Q., (1998) Factors relating to neurotoxicity of artemisinin antimalarial drugs "listening to arteether". Med. Trop. (Mars) 58, 22-27.
41. Nontprasert, A., Pukrittayakamee, S., Nosten-Bertrand, M., Vanijanonta, S., and, White, N. J., (2000) Studies of the neurotoxicity of oral artemisinin derivatives in mice. Am. J. Trop. Med. Hyg. 62, 409-412.
42. Chateauvieux, S., Morceau, F., Dicato, M., and, Diederich, M., (2010) Molecular and therapeutic potential and toxicity of valproic acid. J. Biomed. Biotechnol. 2010, 479364.
43. Lubner, S. J., Kunnimalaiyaan, M., Holen, K. D., Ning, L., Ndiaye, M., et al. (2011) A preclinical and clinical study of lithium in low-grade neuroendocrine tumors. Oncologist 16, 452-457.
44. Chow, L. M., and, Chan, T. H., (2009) Novel classes of dimer antitumour drug candidates. Curr. Pharm. Des. 15, 659-674.
45. Zong, H., Wang, F., Fan, Q. X., and, Wang, L. X., (2011) Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-κB signaling pathways. Mol. Biol. Rep. 39, 4803-4808.
46. Thayyullathil, F., Chathoth, S., Hago, A., Patel, M., and, Galadari, S., (2008) Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells. Free Radic. Biol. Med. 45, 1403-1412.
47. Bhaumik, S., Anjum, R., Rangaraj, N., Pardhasaradhi, B. V., and, Khar, A., (1999) Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett. 456, 311-314.
48. Efferth, T., Benakis, A., Romero, M. R., Tomicic, M., Rauh, R., et al. (2004) Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic. Biol. Med. 37, 998-1009.
49. Joe, B., Vijaykumar, M., and, Lokesh, B. R., (2004) Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 44, 97-111.
50. Fujisawa, S., Atsumi, T., Ishihara, M., and, Kadoma, Y., (2004) Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res. 24, 563-569.
51. Sandur, S. K., Ichikawa, H., Pandey, M. K., Kunnumakkara, A. B., Sung, B., et al. (2007) Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic. Biol. Med. 43, 568-580.
52. Guo, L. D., Chen, X. J., Hu, Y. H., Yu, Z. J., Wang, D., et al. (2013) Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway. Phytother. Res. 27, 422-430.
53. Gao, W., Xiao, F., Wang, X., and, Chen, T., (2013) Artemisinin induces A549 cell apoptosis dominantly via a reactive oxygen species-mediated amplification activation loop among caspase-9, -8 and -3. Apoptosis 18, 1201-1213.
54. Liao, V. H., Yu, C. W., Chu, Y. J., Li, W. H., Hsieh, Y. C., et al. (2011) Curcumin-mediated lifespan extension in Caenorhabditis elegans. Mech. Ageing Dev. 132, 480-487.
55. Purkayastha, S., Berliner, A., Fernando, S. S., Ranasinghe, B., Ray, I., et al. (2009) Curcumin blocks brain tumor formation. Brain Res. 1266, 130-138.